# The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions

> **NCT06244407** · PHASE1 · UNKNOWN · sponsor: **International Bio service** · enrollment: 40 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Vildagliptin and Metformin Hydrochloride 50mg 1000 mg Film-coated Tablets

## Key facts

- **NCT ID:** NCT06244407
- **Lead sponsor:** International Bio service
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-23
- **Primary completion:** 2024-05-25
- **Final completion:** 2024-06-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06244407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06244407, "The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06244407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*